Shahram Oveisgharan to Iran
This is a "connection" page, showing publications Shahram Oveisgharan has written about Iran.
Connection Strength
0.854
-
Enhancement of Motor Recovery through Left Dorsolateral Prefrontal Cortex Stimulation after Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2018 Jan; 27(1):185-191.
Score: 0.157
-
Stroke in Isfahan, Iran: hospital admission and 28-day case fatality rate. Cerebrovasc Dis. 2007; 24(6):495-9.
Score: 0.079
-
Barthel index in a Middle-East country: translation, validity and reliability. Cerebrovasc Dis. 2006; 22(5-6):350-4.
Score: 0.073
-
Preventive effect of greater occipital nerve block on patients with episodic migraine: A randomized double-blind placebo-controlled clinical trial. Cephalalgia. 2022 05; 42(6):481-489.
Score: 0.053
-
Anthropometric indices predicting incident hypertension in an Iranian population: The Isfahan cohort study. Anatol J Cardiol. 2019 06; 22(1):33-43.
Score: 0.044
-
A 10-year Isfahan cohort on cardiovascular disease as a master plan for a multi-generation non-communicable disease longitudinal study: methodology and challenges. J Hum Hypertens. 2019 11; 33(11):807-816.
Score: 0.043
-
Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3. J Clin Neuromuscul Dis. 2018 Jun; 19(4):203-210.
Score: 0.041
-
Whole milk consumption and risk of cardiovascular disease and mortality: Isfahan Cohort Study. Eur J Nutr. 2019 Feb; 58(1):163-171.
Score: 0.040
-
Determinants of Incident Metabolic Syndrome in a Middle Eastern Population: Isfahan Cohort Study. Metab Syndr Relat Disord. 2017 09; 15(7):354-362.
Score: 0.039
-
Metabolic Syndrome and the Risk of Ischemic Stroke. J Stroke Cerebrovasc Dis. 2017 Feb; 26(2):286-294.
Score: 0.037
-
The impact of health-related quality of life on the incidence of ischaemic heart disease and stroke; a cohort study in an Iranian population. Acta Cardiol. 2016 Apr; 71(2):221-6.
Score: 0.036
-
Comparison between European and Iranian cutoff points of triglyceride/high-density lipoprotein cholesterol concentrations in predicting cardiovascular disease outcomes. J Clin Lipidol. 2016 Jan-Feb; 10(1):143-9.
Score: 0.035
-
Determinants of incident prediabetes and type 2 diabetes in a 7-year cohort in a developing country: The Isfahan Cohort Study. J Diabetes. 2015 Sep; 7(5):633-41.
Score: 0.033
-
Heart rate and cardiovascular events: a nested case-control in Isfahan Cohort Study. Arch Iran Med. 2014 Sep; 17(9):633-7.
Score: 0.032
-
Incident hypertension and its predictors: the Isfahan Cohort Study. J Hypertens. 2014 Jan; 32(1):30-8.
Score: 0.030
-
Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Arch Iran Med. 2013 Mar; 16(3):138-44.
Score: 0.029
-
The influence of gender and place of residence on cardiovascular diseases and their risk factors. The Isfahan cohort study. Saudi Med J. 2012 May; 33(5):533-40.
Score: 0.027
-
Appropriate cut-off values of waist circumference to predict cardiovascular outcomes: 7-year follow-up in an Iranian population. Intern Med. 2012; 51(2):139-46.
Score: 0.027